CHAMPSI FARAH
Insider CIK 1198321 · CMRX Director · SCYX 10% owner · PTLA Director · AGTC 10% owner · AEGR 10% owner · LIFE 10% owner · CARA 10% owner · STRO 10% owner · TRVN Director, 10% owner · ESPR 10% owner · IMDZ 10% owner · ZSPH 10% owner · KITE Director · ALLK 10% owner · NEOT 10% owner · PHIC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHIC Population Health Investme | J Other deriv | 2021-01-26 | 2021-01-26 | 43,125 | $250.00 | $10.78M | 43,125 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 11,539 | — | $0 | 11,539 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 6,837 | — | $0 | 6,837 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 34,615 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 34,615 | — | $0 | 34,615 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 1,000,000 | — | $0 | 10,519,200 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 12,387,324 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 9,449,318 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 18,698,578 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 10,201,769 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 458,331 | — | $0 | 1,047,992 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 589,661 | — | $0 | 589,661 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 382,698 | — | $0 | 1,430,690 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 514,211 | — | $0 | 1,944,901 | SEC↗ |
| ALLK Allakos Inc. | C Conversion deriv | 2018-07-23 | 2018-07-23 | 1,239,007 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | C Conversion deriv | 2018-07-23 | 2018-07-23 | 10,030,193 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | C Conversion | 2018-07-23 | 2018-07-23 | 11,269,200 | — | $0 | 11,269,200 | SEC↗ |
| ALLK Allakos Inc. | P Buy | 2018-07-23 | 2018-07-23 | 250,000 | $18.00 | $4.50M | 11,519,200 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 50,000 | $178.65 | $8.93M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $120.77 | $1.21M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | U Tender | 2017-10-03 | 2017-10-05 | 61,467 | $180.00 | $11.06M | 1,807 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 1,807 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | G Gift | 2017-09-29 | 2017-10-05 | 2,800 | — | $0 | 63,274 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 66,074 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-06-16 | 2017-06-16 | 5,450 | $88.11 | $480.2K | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-06-14 | 2017-06-16 | 15,000 | $90.40 | $1.36M | 63,664 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-28 | 2017-05-01 | 2,617 | $82.59 | $216.1K | 4,962 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-27 | 2017-05-01 | 16,551 | $82.77 | $1.37M | 7,579 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-26 | 2017-04-26 | 51,112 | $82.72 | $4.23M | 24,330 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-26 | 2017-04-26 | 200 | $83.06 | $16.6K | 24,130 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-25 | 2017-04-26 | 15,316 | $83.29 | $1.28M | 75,442 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-25 | 2017-04-26 | 31,467 | $82.56 | $2.60M | 90,758 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-24 | 2017-04-26 | 25,818 | $82.34 | $2.13M | 122,225 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-17 | 2017-04-17 | 100 | $83.06 | $8.3K | 148,043 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-17 | 2017-04-17 | 43,001 | $82.48 | $3.55M | 148,143 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-04-13 | 2017-04-17 | 72,275 | $82.39 | $5.95M | 191,144 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2016-06-01 | 2016-06-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2016-06-01 | 2016-06-03 | 1,950 | — | $0 | 21,616 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-30 | 2015-12-30 | 250,000 | $1.44 | $360.0K | 1,339,776 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-29 | 2015-12-30 | 493,654 | $1.53 | $755.3K | 1,589,776 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-28 | 2015-12-30 | 54,333 | $1.59 | $86.4K | 2,083,430 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-15 | 2015-12-17 | 529,261 | $1.44 | $762.1K | 2,137,763 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2015-06-30 | 2015-07-02 | 500 | $63.82 | $31.9K | 1,761,957 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2015-06-30 | 2015-07-02 | 358,757 | $63.01 | $22.61M | 1,762,457 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2015-06-30 | 2015-07-02 | 113,047 | $62.14 | $7.02M | 2,121,214 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2015-06-30 | 2015-07-02 | 191,798 | $61.22 | $11.74M | 2,234,261 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2015-06-09 | 2015-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-08 | 2015-06-09 | 11,200 | $57.53 | $644.3K | 2,646,643 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-05 | 2015-06-09 | 164,227 | $57.88 | $9.51M | 2,657,843 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-04 | 2015-06-05 | 48,913 | $57.71 | $2.82M | 2,822,070 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-04 | 2015-06-05 | 39,495 | $57.21 | $2.26M | 2,870,983 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-03 | 2015-06-05 | 23,189 | $56.60 | $1.31M | 2,910,478 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-02 | 2015-06-02 | 84,342 | $56.77 | $4.79M | 2,933,667 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-01 | 2015-06-02 | 72,520 | $58.00 | $4.21M | 3,018,009 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-05-29 | 2015-06-02 | 124,865 | $58.63 | $7.32M | 3,105,225 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-05-29 | 2015-06-02 | 14,696 | $59.69 | $877.2K | 3,090,529 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 893,655 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 4,361,703 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 4,320,173 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 3,600,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 1,126,866 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 1,685,758 | — | $0 | 1,685,758 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 92,306 | — | $0 | 1,778,064 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-12-10 | 2014-12-10 | 500,000 | $4.00 | $2.00M | 4,390,262 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 750,000 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 6,216,215 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 2,201,220 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 4,489,065 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise deriv | 2014-11-25 | 2014-11-25 | 707,142 | $1.40 | $990.0K | 0 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise deriv | 2014-11-25 | 2014-11-25 | 432,432 | $1.85 | $800.0K | 0 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise deriv | 2014-11-25 | 2014-11-25 | 214,285 | $1.40 | $300.0K | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 1,161,939 | — | $0 | 1,288,824 | SEC↗ |
| NEOT Neothetics, Inc. | P Buy | 2014-11-25 | 2014-11-25 | 70,000 | $14.00 | $980.0K | 2,667,024 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 476,845 | — | $0 | 1,765,669 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 735,912 | — | $0 | 2,501,581 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-11-25 | 93,676 | $11.29 | $1.06M | 2,595,257 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2014-11-25 | 2014-11-25 | 57,143 | $14.00 | $800.0K | 2,538,114 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-11-25 | 115,925 | $8.54 | $990.0K | 2,654,039 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2014-11-25 | 2014-11-25 | 70,714 | $14.00 | $990.0K | 2,583,325 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-11-25 | 35,128 | $8.54 | $300.0K | 2,618,453 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2014-11-25 | 2014-11-25 | 21,429 | $14.00 | $300.0K | 2,597,024 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 122,951 | — | $0 | 126,885 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-12-01 | 93,676 | $8.54 | $800.0K | 2,595,257 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | J Other | 2014-11-17 | 2014-11-19 | 1,492,200 | — | $0 | 1,492,200 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 500,000 | $20.00 | $10.00M | 2,552,189 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 611,620 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | X Exercise deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 305,810 | SEC↗ |
| IMDZ Immune Design Corp. | X Exercise deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 531,843 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 733,943 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 611,620 | — | $0 | 1,877,406 | SEC↗ |
| IMDZ Immune Design Corp. | P Buy | 2014-07-29 | 2014-07-31 | 299,559 | $12.00 | $3.59M | 2,482,775 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 733,943 | — | $0 | 733,943 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 2,183,216 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 531,843 | — | $0 | 1,265,786 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion deriv | 2014-06-25 | 2014-06-27 | 2,158,545 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion | 2014-06-25 | 2014-06-27 | 2,166,889 | — | $0 | 2,166,889 | SEC↗ |
| KITE Kite Pharma, Inc. | J Other | 2014-06-25 | 2014-06-27 | 759,170 | $15.30 | $11.62M | 2,926,059 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion deriv | 2014-06-23 | 2014-06-25 | 2,849,703 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion deriv | 2014-06-23 | 2014-06-25 | 180,387 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion | 2014-06-23 | 2014-06-25 | 3,030,090 | — | $0 | 3,030,090 | SEC↗ |
| ZSPH ZS Pharma, Inc. | P Buy | 2014-06-23 | 2014-06-25 | 200,000 | $18.00 | $3.60M | 3,230,090 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2014-05-14 | 2014-05-15 | 8,870 | — | $0 | 8,870 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion deriv | 2014-05-07 | 2014-05-08 | 1,417,315 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise deriv | 2014-05-07 | 2014-05-08 | 174 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise deriv | 2014-05-07 | 2014-05-08 | 3,033 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion deriv | 2014-05-07 | 2014-05-08 | 20,975 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion deriv | 2014-05-07 | 2014-05-08 | 37,702 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion deriv | 2014-05-07 | 2014-05-08 | 53,915 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise deriv | 2014-05-07 | 2014-05-08 | 4,551 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise deriv | 2014-05-07 | 2014-05-08 | 4,551 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise deriv | 2014-05-07 | 2014-05-08 | 82,454 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion deriv | 2014-05-07 | 2014-05-08 | 570,159 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion deriv | 2014-05-07 | 2014-05-08 | 1,024,876 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise deriv | 2014-05-07 | 2014-05-08 | 174 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion | 2014-05-07 | 2014-05-08 | 1,848 | — | $0 | 11,160 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion | 2014-05-07 | 2014-05-08 | 5,931 | — | $0 | 9,312 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise | 2014-05-07 | 2014-05-08 | 3,033 | $0.20 | $607 | 3,381 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise | 2014-05-07 | 2014-05-08 | 174 | $0.20 | $35 | 348 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise | 2014-05-07 | 2014-05-08 | 174 | $0.20 | $35 | 174 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy | 2014-05-07 | 2014-05-08 | 868,066 | $10.00 | $8.68M | 1,240,575 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion | 2014-05-07 | 2014-05-08 | 69,476 | — | $0 | 372,509 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion | 2014-05-07 | 2014-05-08 | 50,239 | — | $0 | 303,033 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion | 2014-05-07 | 2014-05-08 | 161,238 | — | $0 | 252,794 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise | 2014-05-07 | 2014-05-08 | 82,454 | $0.20 | $16.5K | 91,556 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise | 2014-05-07 | 2014-05-08 | 4,551 | $0.20 | $910 | 9,102 | SEC↗ |
| SCYX SCYNEXIS INC | X Exercise | 2014-05-07 | 2014-05-08 | 4,551 | $0.20 | $910 | 4,551 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy | 2014-05-07 | 2014-05-08 | 31,934 | $10.00 | $319.3K | 45,736 | SEC↗ |
| SCYX SCYNEXIS INC | C Conversion | 2014-05-07 | 2014-05-08 | 2,642 | — | $0 | 13,802 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 23,507,953 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 49,060,606 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 26,437,934 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | P Buy | 2014-04-01 | 2014-04-01 | 155,645 | $12.00 | $1.87M | 2,984,400 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion | 2014-04-01 | 2014-04-01 | 2,828,755 | — | $0 | 2,828,755 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 89,227 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 1,328,604 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 32,742 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 158,741 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 2,363,654 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 58,250 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 4,840,686 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 1,950,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 8,400,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 6,000,000 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 6,940 | $11.00 | $76.3K | 117,760 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 1,118,675 | — | $0 | 1,118,675 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 531,442 | — | $0 | 1,650,117 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 103,330 | $11.00 | $1.14M | 1,753,447 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 2,547 | $11.00 | $28.0K | 43,212 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 13,097 | — | $0 | 40,665 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 27,568 | — | $0 | 27,568 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 35,691 | — | $0 | 110,820 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 75,129 | — | $0 | 75,129 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-02-05 | 2014-02-07 | 472,410 | $7.00 | $3.31M | 3,890,262 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 1,354,838 | — | $0 | 2,322,579 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 967,741 | — | $0 | 967,741 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 314,516 | — | $0 | 2,637,095 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 780,757 | — | $0 | 3,417,852 | SEC↗ |
| CMRX CHIMERIX INC | S Sale | 2013-10-23 | 2013-10-23 | 447,499 | $15.51 | $6.94M | 1,714,330 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 71,237 | — | $0 | 71,237 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 497,666 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-01 | 1,816,475 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 235,714 | $14.00 | $3.30M | 2,052,189 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-01 | 1,816,475 | — | $0 | 1,816,475 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 28,255 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 42,260 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 66,221 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 4,447 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 10,368 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 420,738 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 1,632 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 15,507 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 629,255 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 27,507 | — | $0 | 27,507 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 74,962 | — | $0 | 74,962 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 1,116,214 | — | $0 | 1,116,214 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 688,729 | — | $0 | 1,515,203 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 550,982 | — | $0 | 2,161,829 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 826,474 | — | $0 | 826,474 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-16 | 2012-10-17 | 3,160 | $18.67 | $59.0K | 56,190 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-16 | 2012-10-17 | 128,229 | $18.67 | $2.39M | 2,280,197 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-16 | 2012-10-17 | 8,611 | $18.67 | $160.8K | 153,131 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-15 | 2012-10-17 | 1,371 | $17.54 | $24.0K | 59,350 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-15 | 2012-10-17 | 55,626 | $17.54 | $975.7K | 2,408,426 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-15 | 2012-10-17 | 3,736 | $17.54 | $65.5K | 161,742 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 1,955,991 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 2,444,990 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 2,933,986 | — | $0 | 0 | SEC↗ |